Salvage treatment for radio-recurrent prostate cancer: a review of literature with focus on recent advancements in image-guided focal salvage therapies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s11255-019-02114-4.pdf
Reference42 articles.
1. Loeb S et al (2011) Can we stop prostate specific antigen testing 10 years after radical prostatectomy? J Urol 186(2):500–505
2. Roach M et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65(4):965–974
3. Fakhrejahani F, Madan RA, Dahut WL (2017) Management options for biochemically recurrent prostate cancer. Curr Treat Opt Oncol 18(5):26
4. Grossfeld GD et al (2002) Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol 168(2):530–535
5. Lee WR, Hanks GE, Hanlon A (1997) Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol 15(1):230–238
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Potentiating Salvage Radiotherapy in Radiorecurrent Prostate Cancer Through Anti-CTLA4 Therapy: Implications from a Syngeneic Model;Cancers;2024-08-14
2. A dosimetric analysis of rectal hydrogel spacer use in patients with recurrent prostate cancer undergoing salvage high-dose-rate brachytherapy;Brachytherapy;2023-09
3. A Canadian center’s experience on whole-gland salvage therapy for radio-recurrent prostate cancer with various modalities;Canadian Urological Association Journal;2023-08-29
4. In-bore MR prostate biopsy — initial experience;Endokrynologia Polska;2022-07-18
5. A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents;Biomedicine & Pharmacotherapy;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3